ARG1 and neoplasm: The growing number of arginase-1 generated by MDSCs depletes L-arginine, leading to the G0–G1 phase being blocked during T cell proliferation and the low expression of the CD3ζ chain of the TCR, connected with tumor escape in vivo [24].